Antibiotics & Resistance

Similar documents
Antimicrobials & Resistance

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Antimicrobial Therapy

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut

Chapter 12. Antimicrobial Therapy. Antibiotics 3/31/2010. Spectrum of antibiotics and targets

Antibiotic Resistance in Bacteria

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

Chapter concepts: What are antibiotics, the different types, and how do they work? Antibiotics

Mechanism of antibiotic resistance

Antimicrobial Resistance

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Antimicrobial agents

Introduction to Antimicrobials. Lecture Aim: To provide a brief introduction to antibiotics. Future lectures will go into more detail.

WHY IS THIS IMPORTANT?

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

number Done by Corrected by Doctor Dr Hamed Al-Zoubi

Microbiology : antimicrobial drugs. Sheet 11. Ali abualhija

An#bio#cs and challenges in the wake of superbugs

bacteria fungi HOW? WHAT? protozoa virus Controlling Microbial Growth in the Body: Antimicrobial Drugs

Controlling Microbial Growth in the Body: Antimicrobial Drugs

Antibacterial susceptibility testing

Controlling Microbial Growth in the Body: Antimicrobial Drugs

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

Controlling Microbial Growth in the Body: Antimicrobial Drugs

Controlling Microbial Growth in the Body: Antimicrobial Drugs

Microbiology ( Bacteriology) sheet # 7

Pharm 262: Antibiotics. 1 Pharmaceutical Microbiology II DR. C. AGYARE

Antimicrobial Drugs. PowerPoint Lecture Presentations prepared by Bradley W. Christian, McLennan Community College C H A P T E R

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

Chapter 20. Antimicrobial Drugs. Lectures prepared by Christine L. Case Pearson Education, Inc. Lectures prepared by Christine L.

Principles of Antimicrobial therapy

Introduction to antimicrobial agents

CSLO3. Distinguish between mechanisms of physical and chemical agents to control microbial populations.

Antimicrobials. Antimicrobials

Protein Synthesis Inhibitors

Antimicrobial agents. are chemicals active against microorganisms

Biochrom AG s antibiotics solutions: working concentration. Biochrom AG Information, November 19, 2010

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi

Antibiotic resistance a mechanistic overview Neil Woodford

Should we test Clostridium difficile for antimicrobial resistance? by author

Antimicrobial chemotherapy - history - principles and practice - mode of action, resistance. Dr. Berek Zsuzsa. 01 October 2013

EXPERIMENT. Antibiotic Sensitivity-Kirby Bauer Diffusion Test

Aminoglycosides. Spectrum includes many aerobic Gram-negative and some Gram-positive bacteria.

Cell Wall Inhibitors. Assistant Professor Naza M. Ali. Lec 3 7 Nov 2017

Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice?

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

Responsible use of antimicrobials

control microbial growth in vivo

Antimicrobial use in poultry: Emerging public health problem

Introduction to Pharmacokinetics and Pharmacodynamics

January 2014 Vol. 34 No. 1

folate-derived cofactors purines pyrimidines Sulfonamides sulfa drugs Trimethoprim infecting bacterium to perform DNA synthesis cotrimoxazole

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

DANMAP Danish Integrated Antimicrobial Resistance Monitoring and Research Programme

ANTIBIOTIC Resistance A GLOBAL THREAT Robero JJ

Is erythromycin bactericidal

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

56 Clinical and Laboratory Standards Institute. All rights reserved.

Mechanisms and Pathways of AMR in the environment

ANTIBIOTICS IN PLASMA

BUGS and DRUGS Part 1 March 6, 2013 Marieke Kruidering- Hall

Chemotherapeutic Agents

What is antimicrobial resistance?

Medicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck!

Antibiotics (2): - Before you start: this lecture has a lot of names and things get entangled together, but I

Antibacterial Agents & Conditions. Stijn van der Veen

Overview of antibiotic combination issues.

Surveillance for antimicrobial resistance in enteric bacteria in Australian pigs and chickens

ANTIBIOTIC RESISTANCE. Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh

Other Beta - lactam Antibiotics

Origins of Resistance and Resistance Transfer: Food-Producing Animals.

FACT SHEETS. On the Danish restrictions of non-therapeutical use of antibiotics for growth promotion and its consequences

Introduction to Antimicrobial Therapy

Short Report. R Boot. Keywords: Bacteria, antimicrobial susceptibility testing, quality, diagnostic laboratories, proficiency testing

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1

As antibiotic use increases in veterinary medicine, the issue of bacterial resistance

Introduction to Antimicrobial Therapy

بسم هللا الرحمن الرحيم

Antibiotic Residues in Meat and Meat Products, Implications on Human Health

Multi-drug resistant microorganisms

Antibiotic Resistance Mechanisms, Problems, and Solutions

Antibiotic Resistance The Global Perspective

chapter 15 microbial mechanisms of pathogenicity

10/15/08. Activity of an Antibiotic. Affinity for target. Permeability properties (ability to get to the target)

Lecture 6: Fungi, antibiotics and bacterial infections. Outline Eukaryotes and Prokaryotes Viruses Bacteria Antibiotics Antibiotic resistance

Antimicrobial Resistance and Prescribing

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

Is ABF production supporting or contradicting bird welfare? Maarten De Gussem, DVM Poultry Vaccinology - Ceva Summit March 14th 2016, Barcelona

Project Summary. Impact of Feeding Neomycin on the Emergence of Antibiotic Resistance in E. coli O157:H7 and Commensal Organisms

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Recommended for Implementation at Step 7 of the VICH Process on 15 December 2004 by the VICH Steering Committee

Controlling microbial growth in vivo by using antimicrobial agents. Dr. Nasser M. Kaplan Medical Microbiology JUST, Irbid, Jordan

بسم هللا الرحمن الرحيم

Transcription:

What are antibiotics? Antibiotics & esistance Antibiotics are molecules that stop bacteria from growing or kill them Antibiotics, agents against life - either natural or synthetic chemicals - designed to block some crucial process in bacterial cells Why do we use antibiotics? - To treat bacterial infections - To prevent bacterial infections Bacteriostatic vs Bactericidal Bactericidal - apidly kill the target bacteria Bacteriostatic - Inhibit the growth of bacteria Spectrum Narrow spectrum: Some bacteria Gram-positive Gram-negative Broad spectrum: Both Gram-positive and Gram-negative Growth Normal growth Bacteriostatic Gram-positive? Gram-negative? Some bacteria? Bactericidal time 1

Minimum Inhibitory Concentration (MIC) - The minimum concentration of the drug necessary to inhibit the growth of bacteria High MIC Antibiotic concentration Low Antibiotic Targets Selective Toxicity - Antibiotics should be toxic for bacteria not for the host - Antibiotic targets should be present uniquely in bacteria Cell wall : β-lactam antibiotics (penicillins, cephalosporins) glycopeptides (vancomycin) Membrane: polypeptides (polymyxin) Bacteria 1 More resistant Bacteria 2 DNA NA Protein DNA gyrase: quinolones, novobiocin DNA synthesis: sulphonamides DNA structure: metronidazole NA-polymerase: rifampin Protein synthesis: -30S: aminoglycosides, tetracyclines -50S: chloramphenicol, macrolides, lincosamides :Peptidoglycan synthesis :Peptidoglycan synthesis N-acetyl amino sugars Transglycosylase Transpeptidase Peptide 2

β-lactams (Penicillins) - The β lactam ring is structurally similar to the substrate (Dalanyl-D-alanine) of transpeptidase enzymes Cephalosporins - Action mechanism is similar to penicillins - Advantages: 1. esistance to penicillinase 2. Not as allergenic as penicillin 3. Broad spectrum of activity Penicillin binds to the transpeptidase (they are often referred to as penicillin binding protein (PBP) Preventing the synthesis of peptidoglycan Weakening the peptdidoglycan Bacterium bursts cephalosporin Cell membrane inhibitors Bacitracin - A polypeptide isolated from Bacillus subtilis that interact with the bacterial cell wall Vancomycin - Prevent the synthesis of peptidoglycan - Used to treat serious staphylococcal infections in humans - Binds to D-Ala-D-Ala Transglycosylase Polymyxin - Binds to the outer surface of the cell membranes and disrupt the structure - Active against Gram-negatives but limitedly used for topical applications O antigen - Core - LipidA - Transpeptidase Peptide Cationic Polypeptide + - O antigen Core Lipid A 3

Targeting DNA/NA Inhibition of growth by analogues Quinolones - Inhibit DNA gyrase A and topoisomerase IV Selectively block DNA synthesis - Totally synthetic antimicrobials Novobiocin -Inhibit DNA gyrase B Metronidazole - Its reduction by ferredoxin Generates toxic free radicals DNA damage DNA gyrase NA polymerase Sulfonamides - Bacteria require para aminobenzoic acid (PABA) to form folic acids cf. Eukaryotes can transport folates via membrane transport proteins - The sulfa drugs are analogues of PABA and compete with it DNA synthesis ifampin - Bind to DNA-dependent NA polymerase of bacteria inhibit NA synthesis DHF sulfonamide Targeting Protein Synthesis Targeting 30S ribosomal subunit 1. Aminoglycoside antimicrobials - Streptomycin, neomycin, kanamycin, gentamicin, spectinomycin 2. Tetracycline - Widely used in veterinary medicine - Staining of calcified tissues (teeth and bones) a problem in human medicine Targeting Protein Synthesis Targeting 50S ribosomal subunit 1. Chloramphenicol - A low percentage of humans develop a severe anemia if treated with this drug Strictly prohibited in food-producing animals 2. Florfenicol - A structural analog of chloramphenicol w/o the same side effects 3. Macrolide - Broad spectrum may eliminate much of the normal flora in the intestines 4. Lincosamide - Lyncomycin: Commonly used in feed in the US - Clindamycin: Commonly used in human medicine 4

Antibiotic Targets Antibiotic esistance Cell wall : β-lactam antibiotics (penicillins, cephalosporins) glycopeptides (vancomycin) Membrane: polypeptides (polymyxin) DNA NA Protein DNA gyrase: quinolones, novobiocin DNA synthesis: sulphonamides DNA structure: metronidazole NA-polymerase: rifampin Protein synthesis: -30S: aminoglycosides, tetracyclines -50S: chloramphenicol, macrolides, lincosamides Overall esistance Mechanisms Transfer of Antibiotic esistance Genes Hydrophobic antibiotics Hydrophilic antibiotics Natural transformation Horizontal transfer Porin Bacterial transduction Pump Bacterial conjugation Nature eviews Microbiology, 2006. 4:36-45 5

How to measure antibiotic resistance? :Dilution Susceptibility Tests Broth Dilution Antimicrobial Susceptibility Tests Disk diffusion (Kirby-Bauer) test High Antibiotic concentration Low Agar Dilution Lawn of test bacterium High Antibiotic concentration Low Epsilometer test (Etest) Antimicrobial Susceptibility Tests What causes antibiotic resistance? :Use of Antibiotics in Farm Animals 90% Growth promoter 80% for agriculture Farm Animals 50 M lb. of antibiotics / year 6

Percent response relative to control 8/30/2011 Jan 21, 2002 Antibiotic Growth Promoter To improve growth and to prevent disease in animals The first report on antibiotic growth promoter (Stokstad et al. 1949) Feed chickens with the fermented mash of Streptomyces aureofaciens S. aureofaciens can produce tetracyclines Supplement Level in diet per kilo None 103 g (3) S. aureofaciens 2.5 g 140 g (7) S. aureofaciens 5 g 210 g (10) S. aureofaciens 10 g 230 g (11) Weight (No of survivors) at 25 days Antibiotic Growth Promoter Antibiotic growth promoters enhance weight gain in swine 120 Control 115 Antibiotic 110 Mechanisms of Growth Promotion by Antibiotics Mechanisms are not known, but gut flora are thought to be involved Growth promotion by antibiotics doesn t occur in germfree animals (Coates et al. 1963) Intestine 105 100 95 90 Starter Grower Grower-Finisher Starter phase (~20kg): pooled data from 387 experiments Grower phase (20~50 kg): pooled data from 276 experiments Grower-finisher phase (50kg ~ ): pooled data from 279 experiments Growth Promotion & Disease Prevention Gaskins et al. 2002 7

Enrichment of esistant Bacteria Suppression or elimination of antibiotic-sensitive strains Ban of Antibiotic Growth Promoter Pros - educed the amount of antibiotics used in animals - Decreased antibiotic resistance Ban Intestine Amplification of antibiotic-resistant strains Macrolide resistance in Campylobacter coli from pigs in Denmark Cons - Frequency of diseases use of therapeutic antibiotics - Weight gain production Spread of esistant Bacteria from Farm to Wildlife Isolation of E. coli & Determination of Antibiotic esistance Swine Farm Frequency of detection (FOD*) of antibiotic resistance genes Animal feeing operation lagoons Wastewater treatment plants tet(c) tet(e) tet(h) tet(m) tet(o) tet(w) sul(i) sul(ii) 0.77 0.28 0.89 1.00 0.85 0.96 1.00 0.94 0.91 0.45 0.36 0.91 0.91 1.00 1.00 0.82 Pristine river 0.08 0.00 0.04 0.25 0.08 0.23 0.04 0.17 *FOD = No of detection / No of samples 8

Hypervirulent pathogens contact Failure of antibiotic chemotherapy Extended illnesses and high mortality! How to handle this problem? Avoidance of any unnecessary use of antibiotics Elimination of nontherapeutic uses Development of alternatives to improve animal health Probiotics/ Competitive exclusion products - Prevention of colonization by pathogenic bacteria in the intestines In-feed exogenous enzymes - Phytases, carbohydrases, etc from fermented bacteria or fungi - Improve conversion efficiency of plant-based diets in animals Vaccination - However, many animal diseases still can not be controlled by vaccination 9